Disis ML - Search Results

1

Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine.

Disis ML, Grabstein KH, Sleath PR, Cheever MA. Disis ML, et al. Clin Cancer Res. 1999 Jun;5(6):1289-97. Clin Cancer Res. 1999. PMID: 10389911 Clinical Trial.

2

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

Disis ML, Calenoff E, McLaughlin G, Murphy AE, Chen W, Groner B, Jeschke M, Lydon N, McGlynn E, Livingston RB, et al. Disis ML, et al. Cancer Res. 1994 Jan 1;54(1):16-20. Cancer Res. 1994. PMID: 7505195

3

Induction of T cells specific for the mutated segment of oncogenic P21ras protein by immunization in vivo with the oncogenic protein.

Peace DJ, Smith JW, Disis ML, Chen W, Cheever MA. Peace DJ, et al. Among authors: disis ml. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):110-4. doi: 10.1097/00002371-199308000-00005. J Immunother Emphasis Tumor Immunol. 1993. PMID: 7506572

4

In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein.

Disis ML, Smith JW, Murphy AE, Chen W, Cheever MA. Disis ML, et al. Cancer Res. 1994 Feb 15;54(4):1071-6. Cancer Res. 1994. PMID: 7508819

5

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.

Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA. Bernhard H, et al. Among authors: disis ml. Cancer Res. 1995 Mar 1;55(5):1099-104. Cancer Res. 1995. PMID: 7532543

6

Immunity to the HER-2/neu oncogenic protein.

Disis ML, Bernhard H, Gralow JR, Hand SL, Emery SR, Calenoff E, Cheever MA. Disis ML, et al. Ciba Found Symp. 1994;187:198-207; discussion 207-11. doi: 10.1002/9780470514672.ch13. Ciba Found Symp. 1994. PMID: 7540970 Review.

7

Immunity to oncogenic proteins.

Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W. Cheever MA, et al. Among authors: disis ml. Immunol Rev. 1995 Jun;145:33-59. doi: 10.1111/j.1600-065x.1995.tb00076.x. Immunol Rev. 1995. PMID: 7590829 Review. No abstract available.

8

CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients.

Qin H, Chen W, Takahashi M, Disis ML, Byrd DR, McCahill L, Bertram KA, Fenton RG, Peace DJ, Cheever MA. Qin H, et al. Among authors: disis ml. Cancer Res. 1995 Jul 15;55(14):2984-7. Cancer Res. 1995. PMID: 7606715

9

T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

Cheever MA, Chen W, Disis ML, Takahashi M, Peace DJ. Cheever MA, et al. Among authors: disis ml. Ann N Y Acad Sci. 1993 Aug 12;690:101-12. doi: 10.1111/j.1749-6632.1993.tb44000.x. Ann N Y Acad Sci. 1993. PMID: 8103658 Review.

10

Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein.

Disis ML, Gralow JR, Bernhard H, Hand SL, Rubin WD, Cheever MA. Disis ML, et al. J Immunol. 1996 May 1;156(9):3151-8. J Immunol. 1996. PMID: 8617935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters